- Trials with a EudraCT protocol (51)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
51 result(s) found for: Disorders of Consciousness.
Displaying page 1 of 3.
EudraCT Number: 2021-002321-23 | Sponsor Protocol Number: V1ComplexitDOC | Start Date*: 2022-03-21 |
Sponsor Name:University of Liège | ||
Full Title: Complexity-enhancing drugs to treat disorders of consciousness (DoC): a ketamine study | ||
Medical condition: Disorders of consciousness as Unresponsive Wakefulness Syndrome (UWS) and Minimally Conscious State (MCS) after a coma due to acquired brain injury. Patients who emerged from the minimally consciou... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2021-001453-31 | Sponsor Protocol Number: CONMED3 | Start Date*: Information not available in EudraCT | ||||||||||||||||
Sponsor Name:Copenhagen University Hospital Rigshospitalet | ||||||||||||||||||
Full Title: Automated pupillometry and NIRS-EEG to detect signatures of consciousness in acute brain injury after apomorphine and methylphenidate stimulation: A placebo-controlled, randomized, cross-over study | ||||||||||||||||||
Medical condition: We investigate the possible effects of commercially available apomorphine and methylphenidate on signatures of consciousness in patients admitted to the ICU with acute disorder of consciousness, us... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-003144-23 | Sponsor Protocol Number: 2017/81 | Start Date*: 2018-09-05 |
Sponsor Name:University of Liège | ||
Full Title: Treating severe brain-injured patients with apomorphine : a behavioural and neuroimaging study | ||
Medical condition: Disorders of consciousness | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2009-017904-95 | Sponsor Protocol Number: P09-005 | Start Date*: 2010-06-28 | ||||||||||||||||||||||||||||||||||||
Sponsor Name:Upsher-Smith Laboratories, Inc. | ||||||||||||||||||||||||||||||||||||||
Full Title: Open-Label Extension Study to Evaluate the Safety of USL255 as Adjunctive Therapy in Patients with Refractory Partial-Onset Seizures who had Participated in P09-004, a Randomized, Multicenter, Doub... | ||||||||||||||||||||||||||||||||||||||
Medical condition: Refractory partial-onset seizures with or without secondary generalization | ||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||
Trial protocol: BE (Completed) DE (Completed) ES (Completed) GR (Completed) HU (Completed) | ||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-016996-31 | Sponsor Protocol Number: P09-004 | Start Date*: 2010-06-28 | ||||||||||||||||||||||||||||||||||||
Sponsor Name:Upsher-Smith Laboratories, Inc. | ||||||||||||||||||||||||||||||||||||||
Full Title: A Randomized, Multicenter, Double-Blind, Placebo–Controlled, Parallel-Group, Phase 3 Study to Evaluate the Efficacy and Safety of USL255 as Adjunctive Therapy in Patients with Refractory Partial-O... | ||||||||||||||||||||||||||||||||||||||
Medical condition: Refractory partial-onset seizures with or without secondary generalization | ||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||
Trial protocol: BE (Completed) DE (Completed) ES (Completed) GR (Completed) HU (Completed) | ||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-005440-25 | Sponsor Protocol Number: SP904 | Start Date*: 2009-02-16 | ||||||||||||||||
Sponsor Name:UCB BIOSCIENCES, Inc. | ||||||||||||||||||
Full Title: A Multicenter, Open-label Extension Trial to Assess the Long-term Use of Lacosamide Monotherapy and Safety of Lacosamide Monotherapy and Adjunctive Therapy in Subjects with Partial-onset Seizures | ||||||||||||||||||
Medical condition: Partial-onset seizures (with and without secondary generalization) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) IE (Completed) ES (Completed) AT (Completed) DK (Completed) PT (Not Authorised) IT (Completed) FR (Completed) DE (Completed) Outside EU/EEA | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2007-005439-27 | Sponsor Protocol Number: SP902 | Start Date*: 2009-02-16 | ||||||||||||||||
Sponsor Name:UCB BIOSCIENCES, Inc. | ||||||||||||||||||
Full Title: A Historical-controlled, Multicenter, Double-blind, Randomized Trial to Assess the Efficacy and Safety of Conversion to Lacosamide 400mg/day Monotherapy in Subjects with Partial-onset Seizures | ||||||||||||||||||
Medical condition: Partial-onset seizures (with or without secondary generalization) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) IE (Completed) ES (Completed) AT (Completed) DK (Completed) PT (Not Authorised) IT (Completed) FR (Completed) DE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2019-001898-87 | Sponsor Protocol Number: STRIVE | Start Date*: 2019-09-26 | |||||||||||||||||||||
Sponsor Name:FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA | |||||||||||||||||||||||
Full Title: Pilot study on sleep pathologies treatments in patients with Vegetative or Minimally conscious state diagnosis for improving Consciounsess level. STRIVE Project. | |||||||||||||||||||||||
Medical condition: Patients diagnosed with vegetative state or minimally conscious state following brain damages without previous either psychiatric or neurological history and with evidence of (i) Obstructive Sleep ... | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-003248-36 | Sponsor Protocol Number: 61383082 | Start Date*: 2011-09-30 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Central Military Hospital | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: The clinical significance of epigenetic factors research to refine the diagnosis, estimate prognosis and risk of recurrence after curative pancreatic cancer resection. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: The aim of the study to estimate frequence of epigenetics changes in pancreatic cancer and to assess the signidicance of apllication of the intravenous contrast agent during endosonography to bette... | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: CZ (Ongoing) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-002942-33 | Sponsor Protocol Number: GWEP1428 | Start Date*: 2015-10-27 | |||||||||||
Sponsor Name:GW Research Ltd | |||||||||||||
Full Title: A phase 2, double-blind, randomized, placebo-controlled study to investigate possible drug-drug interactions between clobazam and cannabidiol (GWP42003-P) | |||||||||||||
Medical condition: | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-005541-12 | Sponsor Protocol Number: 2011-397 | Start Date*: 2012-02-27 | |||||||||||
Sponsor Name:Grethe Andersen | |||||||||||||
Full Title: Efficacy of escitalopram treatment in acute stroke and the role of SERT genotype in stroke | |||||||||||||
Medical condition: Stroke | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2022-003703-16 | Sponsor Protocol Number: GR-2021-12375001 | Start Date*: Information not available in EudraCT | ||||||||||||||||
Sponsor Name:OSPEDALE SAN RAFFAELE | ||||||||||||||||||
Full Title: The effect of phoSPHocreatine on mEdical emergency team (met) tREated patients: a randomized clinical trial protocol - SPHERE. | ||||||||||||||||||
Medical condition: Patients with worsening clinical condition requiring MET intervention and in general ward | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-019035-35 | Sponsor Protocol Number: A0081194 | Start Date*: 2011-02-21 | |||||||||||
Sponsor Name:Pfizer Inc. | |||||||||||||
Full Title: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP, MULTI-CENTER TRIAL OF PREGABALIN CONTROLLED RELEASE FORMULATION AS ADJUNCTIVE THERAPY IN ADULTS WITH PARTIAL ONSET SEIZURES - PROTOCO... | |||||||||||||
Medical condition: Adjunctive (add on) therapy for adult subjects with partial onset seizures with or without secondary generalization. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) HU (Completed) DE (Completed) BG (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-000202-20 | Sponsor Protocol Number: RC-P0041 | Start Date*: 2015-06-22 | |||||||||||||||||||||||||||||||
Sponsor Name:Groupement des Hôpitaux de l’Institut Catholique de Lille (GHICL) | |||||||||||||||||||||||||||||||||
Full Title: Effect and tolerance of ketamine's subcutaneous bolus during painful care, refractory of bedsore, ulcer, vascular wound care in palliative care units. | |||||||||||||||||||||||||||||||||
Medical condition: Patients’ palliative care for bedsores, ulcers or vascular wounds, which are general characteristics of the patient population that will be included: usually elderly, undernourished and of multiple... | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-002939-18 | Sponsor Protocol Number: GWEP1447 | Start Date*: 2016-04-29 | |||||||||||
Sponsor Name:GW Research Ltd. | |||||||||||||
Full Title: A phase 2, double-blind, randomized, placebo-controlled pharmacokinetic trial in two parallel groups to investigate possible drug- drug interactions between stiripentol or valproate and GWP42003-P ... | |||||||||||||
Medical condition: Epilepsy | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) SE (Completed) NL (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-003003-30 | Sponsor Protocol Number: 2014-853 | Start Date*: 2014-10-31 | |||||||||||
Sponsor Name:HOSPICES CIVILS DE LYON | |||||||||||||
Full Title: ENALEPSIE EFFICACY OF NALOXONE IN REDUCING POSTICTAL CENTRAL RESPIRATORY DYSFUNCTION IN PATIENTS WITH EPILEPSY. | |||||||||||||
Medical condition: Sudden unexpected death in epilepsy (SUDEP) primarily affects young adults with drug-resistant epilepsy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-003522-25 | Sponsor Protocol Number: APHP180672 | Start Date*: 2020-02-28 |
Sponsor Name:AP-HP | ||
Full Title: | ||
Medical condition: acute osteomyelitis of the child | ||
Disease: | ||
Population Age: Children, Under 18 | Gender: Male, Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2010-023678-38 | Sponsor Protocol Number: GR-2008-1138784 sottostudio | Start Date*: 2011-04-20 | |||||||||||
Sponsor Name:FONDAZIONE CENTRO S. RAFFAELE DEL MONTE TABOR | |||||||||||||
Full Title: High-field structural and functional MRI to investigate the substrates of fatigue in multiple sclerosis and to monitor the effect of tailored treatments.Pharmacological substudy. | |||||||||||||
Medical condition: patients with multiple sclerosis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-000592-17 | Sponsor Protocol Number: MODY-TREAT | Start Date*: 2012-08-03 | |||||||||||
Sponsor Name:Signe H. Østoft, Diabetes Research Division | |||||||||||||
Full Title: The effects of GLP-1 in Maturity- onset diabetes of the young (MODY) | |||||||||||||
Medical condition: 'Maturity onset diabetes of the young', also called 'Hepatocyte nuclear factor 1-alfa daiabetes'. It is a monogenic form of inherited diabetes. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-001260-29 | Sponsor Protocol Number: 2012-CARDAF | Start Date*: 2012-04-24 | |||||||||||
Sponsor Name:FONDAZIONE ISTITUTO SAN RAFFAELE-G.GIGLIO | |||||||||||||
Full Title: Identification of predictive plasma Biomarkers and use of a high dosage statin during a procedure of Parrossistic Atrial Fibrillation pharmacological Cardioversion | |||||||||||||
Medical condition: Parossistic Atrial Fibrillation according to the European Socierty of Cardiology (ESC)criteria | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.